Cargando…
Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?
Alzheimer’s disease (AD) is one of the most common causes of dementia. Its pathogenesis is characterized by the aggregation of the amyloid-β (Aβ) protein in senile plaques and the hyperphosphorylated tau protein in neurofibrillary tangles in the brain. Current medications for AD can provide temporar...
Autores principales: | Dong, Yuan, Li, Xiaoheng, Cheng, Jinbo, Hou, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386861/ https://www.ncbi.nlm.nih.gov/pubmed/30696107 http://dx.doi.org/10.3390/ijms20030558 |
Ejemplares similares
-
Non-Coding RNA in Microglia Activation and Neuroinflammation in Alzheimer’s Disease
por: He, Chunxiang, et al.
Publicado: (2023) -
Microglial Calhm2 regulates neuroinflammation and contributes to Alzheimer’s disease pathology
por: Cheng, Jinbo, et al.
Publicado: (2021) -
The effects of microglia-associated neuroinflammation on Alzheimer’s disease
por: Wang, Cuicui, et al.
Publicado: (2023) -
Neuroinflammation, Microglia and Implications for Anti-Inflammatory Treatment in Alzheimer's Disease
por: Krause, Daniela L., et al.
Publicado: (2010) -
Targeting neuroinflammation in Alzheimer’s disease
por: Bronzuoli, Maria Rosanna, et al.
Publicado: (2016)